Fourth Quarter Revenue Growth Accelerates; Operating Losses Notably Moderate SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced financial results
First partnership in the new QIAseq Platform Partnership to increase compatibility of QIAGEN NGS kits with third-party digital data-sharing and analytics companies Bringing together QIAGEN's
/PRNewswire/ SOPHiA GENETICS (Nasdaq: SOPH), a leader in Data-Driven Medicine, have announced, in conjunction with Assises de Génétique, an extension of.